Anterogen Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seoul Korea, Republic of (2000)

Organization Overview

First Clinical Trial
2004
NCT00992147
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Anterogen Co., Ltd.